Discovery and structure-activity relationships of pyrrolone antimalarials

Dinakaran Murugesan, Alka Mital, Marcel Kaiser, David Shackleford, Julia Morizzi, Kasiram Katneni, Michael Campbell, Alan Hudson, Susan Ann Charman, Clive Yeates, Ian Hugh Gilbert

Research output: Contribution to journalArticleResearchpeer-review

37 Citations (Scopus)


In the pursuit of new antimalarial leads, a phenotypic screening of various commercially sourced compound libraries was undertaken by the World Health Organisation Programme for Research and Training in Tropical Diseases (WHO-TDR). We report here the detailed characterization of one of the hits from this process, TDR32750 (8a), which showed potent activity against Plasmodium falciparum K1 (EC50 9 nM), good selectivity (>2000-fold) compared to a mammalian cell line (L6), and significant activity against a rodent model of malaria when administered intraperitoneally. Structure-activity relationship studies have indicated ways in which the molecule could be optimized. This compound represents an exciting start point for a drug discovery program for the development of a novel antimalarial.
Original languageEnglish
Pages (from-to)2975 - 2990
Number of pages16
JournalJournal of Medicinal Chemistry
Issue number7
Publication statusPublished - 2013

Cite this